1. Home
  2. GSBD vs SDGR Comparison

GSBD vs SDGR Comparison

Compare GSBD & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSBD

Goldman Sachs BDC Inc.

HOLD

Current Price

$9.23

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$11.39

Market Cap

854.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSBD
SDGR
Founded
2012
1990
Country
United States
United States
Employees
N/A
850
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
854.2M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
GSBD
SDGR
Price
$9.23
$11.39
Analyst Decision
Sell
Buy
Analyst Count
2
8
Target Price
$9.00
$21.13
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
14.32%
N/A
EPS Growth
87.27
45.14
EPS
1.03
N/A
Revenue
N/A
$255,869,000.00
Revenue This Year
N/A
$1.20
Revenue Next Year
N/A
$4.36
P/E Ratio
$8.91
N/A
Revenue Growth
N/A
23.29
52 Week Low
$8.81
$11.11
52 Week High
$12.38
$27.63

Technical Indicators

Market Signals
Indicator
GSBD
SDGR
Relative Strength Index (RSI) 50.32 36.15
Support Level $8.94 $11.11
Resistance Level $9.53 $13.36
Average True Range (ATR) 0.19 0.54
MACD 0.01 -0.01
Stochastic Oscillator 49.37 1.68

Price Performance

Historical Comparison
GSBD
SDGR

About GSBD Goldman Sachs BDC Inc.

Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests primarily in U.S. middle-market companies such as banks and the public debt markets. The company focuses on the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: